{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T00:25:44Z","timestamp":1790987144800,"version":"4.1.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.ajog.2015.11.022","type":"journal-article","created":{"date-parts":[[2015,11,30]],"date-time":"2015-11-30T01:45:17Z","timestamp":1448847917000},"page":"657.e1-657.e9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["Fluconazole use and birth defects in the National Birth Defects Prevention Study"],"prefix":"10.1016","volume":"214","author":[{"given":"Meredith M.","family":"Howley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tonia C.","family":"Carter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilyn L.","family":"Browne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul A.","family":"Romitti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher M.","family":"Cunniff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte M.","family":"Druschel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2015.11.022_bib1","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1016\/S0140-6736(07)60917-9","article-title":"Vulvovaginal candidosis","volume":"369","author":"Sobel","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2015.11.022_bib2","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1002\/(SICI)1096-8628(19971031)72:3<253::AID-AJMG1>3.0.CO;2-S","article-title":"Multiple malformation syndrome following fluconazole use in pregnancy: report of an additional patient","volume":"72","author":"Aleck","year":"1997","journal-title":"Am J Med Genet"},{"key":"10.1016\/j.ajog.2015.11.022_bib3","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1097\/00006454-199211120-00017","article-title":"Congenital malformations in an infant born to a woman treated with fluconazole","volume":"11","author":"Lee","year":"1992","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.ajog.2015.11.022_bib4","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1002\/bdra.20189","article-title":"Prenatal exposure to fluconazole: an identifiable dysmorphic phenotype","volume":"73","author":"Lopez-Rangel","year":"2005","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"10.1016\/j.ajog.2015.11.022_bib5","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1093\/clinids\/22.2.336","article-title":"Fluconazole-induced congenital anomalies in three infants","volume":"22","author":"Pursley","year":"1996","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.ajog.2015.11.022_bib6","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1002\/(SICI)1097-0223(199808)18:8<862::AID-PD347>3.0.CO;2-F","article-title":"Fluconazole teratogenicity","volume":"18","author":"Sanchez","year":"1998","journal-title":"Prenat Diagn"},{"key":"10.1016\/j.ajog.2015.11.022_bib7","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1002\/bdra.10022","article-title":"Pathogenic pathways in fluconazole-induced branchial arch malformations","volume":"67","author":"Menegola","year":"2003","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"10.1016\/j.ajog.2015.11.022_bib8","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.reprotox.2003.09.004","article-title":"Relationship between hindbrain segmentation, neural crest cell migration and branchial arch abnormalities in rat embryos exposed to fluconazole and retinoic acid in\u00a0vitro","volume":"18","author":"Menegola","year":"2004","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.ajog.2015.11.022_bib9","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1203\/01.PDR.0000166754.24957.73","article-title":"Murine teratology of fluconazole: evaluation of developmental phase specificity and dose dependence","volume":"58","author":"Tiboni","year":"2005","journal-title":"Pediatr Res"},{"key":"10.1016\/j.ajog.2015.11.022_bib10","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.reprotox.2009.01.001","article-title":"Fluconazole alters CYP26 gene expression in mouse embryos","volume":"27","author":"Tiboni","year":"2009","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.ajog.2015.11.022_bib11","series-title":"Diflucan (Fluconazole Tablets) [package labeling]","year":"2013"},{"key":"10.1016\/j.ajog.2015.11.022_bib12","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1177\/106002809703100119","article-title":"Fluconazole treatment for vulvovaginal candidiasis during pregnancy","volume":"31","author":"Campomori","year":"1997","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.ajog.2015.11.022_bib13","first-page":"115","article-title":"Safety of fluconazole in the treatment of vaginal candidiasis. A prescription-event monitoring study, with special reference to the outcome of pregnancy","volume":"46","author":"Inman","year":"1994","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.ajog.2015.11.022_bib14","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1592\/phco.19.3.221.30919","article-title":"Pregnancy outcomes after maternal exposure to fluconazole","volume":"19","author":"Jick","year":"1999","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ajog.2015.11.022_bib15","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1016\/S0002-9378(96)70119-9","article-title":"Prospective assessment of pregnancy outcomes after first-trimester exposure to fluconazole","volume":"175","author":"Mastroiacovo","year":"1996","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.11.022_bib16","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1093\/jac\/dkn157","article-title":"Maternal use of fluconazole and risk of congenital malformations: a Danish population-based cohort study","volume":"62","author":"N\u00f8rgaard","year":"2008","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.ajog.2015.11.022_bib17","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1046\/j.1365-2125.1999.00989.x","article-title":"Risk of malformations and other outcomes in\u00a0children exposed to fluconazole in utero","volume":"48","author":"S\u00f8rensen","year":"1999","journal-title":"Br J\u00a0Clin Pharmacol"},{"key":"10.1016\/j.ajog.2015.11.022_bib18","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/jac\/dku355","article-title":"Antifungal drugs during pregnancy: an updated review","volume":"70","author":"Pilmis","year":"2015","journal-title":"J\u00a0Antimicrob Chemother"},{"key":"10.1016\/j.ajog.2015.11.022_bib19","doi-asserted-by":"crossref","first-page":"191.e1","DOI":"10.1016\/j.ajog.2007.08.044","article-title":"Antifungal drugs and the risk of selected birth defects","volume":"198","author":"Carter","year":"2008","journal-title":"Am J\u00a0Obstet Gynecol"},{"key":"10.1016\/j.ajog.2015.11.022_bib20","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1056\/NEJMoa1301066","article-title":"Use of oral fluconazole during pregnancy and the risk of birth defects","volume":"369","author":"M\u00f8lgaard-Nielsen","year":"2013","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2015.11.022_bib21","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.reprotox.2015.02.009","article-title":"Exposure to fluconazole and risk of congenital malformations in the offspring: a systematic review and meta-analysis","volume":"52","author":"Alsaad","year":"2015","journal-title":"Reprod Toxicol"},{"key":"10.1016\/j.ajog.2015.11.022_bib22","first-page":"1","article-title":"Sexually transmitted diseases treatment guidelines 2002","volume":"51","year":"2002","journal-title":"MMWR Recomm Rep"},{"issue":"55","key":"10.1016\/j.ajog.2015.11.022_bib23","first-page":"1","article-title":"Centers for\u00a0Disease Control and Prevention. Sexually transmitted diseases treatment guidelines","volume":"2006","author":"Workowski","year":"2006","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.ajog.2015.11.022_bib24","unstructured":"US Food and Drug Administration Drug Safety Communication: Use of long-term, high-dose Diflucan (fluconazole) during pregnancy may be associated with birth defects in\u00a0infants. Rockville, MD: 2011. Available at: http:\/\/www.fda.gov\/Drugs\/DrugSafety\/ucm266030.htm. Accessed October 22,\u00a02014."},{"key":"10.1016\/j.ajog.2015.11.022_bib25","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1002\/bdra.23384","article-title":"The\u00a0National Birth Defects Prevention Study: a Review of the Methods","volume":"103","author":"Reefhuis","year":"2015","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"10.1016\/j.ajog.2015.11.022_bib26","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/bdra.10012","article-title":"Guidelines for case classification for the National Birth Defects Prevention Study","volume":"67","author":"Rasmussen","year":"2003","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"10.1016\/j.ajog.2015.11.022_bib27","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1002\/bdra.20403","article-title":"Seeking causes: classifying and evaluating congenital heart defects in etiologic studies","volume":"79","author":"Botto","year":"2007","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"10.1016\/j.ajog.2015.11.022_bib28","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.annepidem.2011.08.002","article-title":"Use of antiepileptic medications in pregnancy in relation to risks of birth defects","volume":"21","author":"Werler","year":"2011","journal-title":"Ann Epidemiol"},{"key":"10.1016\/j.ajog.2015.11.022_bib29","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1597\/09-217","article-title":"Prevalence at birth of cleft lip with or without cleft palate: data from the International Perinatal Database of Typical Oral Clefts (IPDTOC)","volume":"48","year":"2011","journal-title":"Cleft Palate Craniofac J"},{"key":"10.1016\/j.ajog.2015.11.022_bib30","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1002\/bdra.20735","article-title":"Updated National Birth Prevalence estimates for selected birth defects in the United States, 2004-2006","volume":"88","author":"Parker","year":"2010","journal-title":"Birth Defects Res A Clin Mol Teratol"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937815023959?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937815023959?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T11:09:05Z","timestamp":1757588945000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937815023959"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["S0002937815023959"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2015.11.022","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.725996613.793518674","asserted-by":"object"}]},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fluconazole use and birth defects in the National Birth Defects Prevention Study","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2015.11.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}